Robert Torray – Torray Fund Portfolio Activity & Recent Trades (Jun 30, 2025)
As of Jun 30, 2025, the Torray Fund portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 05, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q2 2025, the filing reported:
New Buys – Chevron Corporation (CVX), Rolls Royce Holdings plc (RYCEY), Taiwan Semiconductor Manufactur (TSM), Krystal Biotech, Inc. (KRYS), Rocket Lab USA, Inc. (RKLB), and 2 more
Increases – Pfizer, Inc. (PFE), CNA Financial Corporation (CNA), Blackstone Inc. (BX), Prologis, Inc. (PLD), Broadcom Inc. (AVGO), and 16 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
Torray Fund Activity
| Date | Symbol | Type | Quantity |
|---|---|---|---|
Q4 2023Dec 31, 2023 | ADBE Adobe Inc. | Sell | -1,210-8.9% |
Q4 2023Dec 31, 2023 | BPMC Blueprint Medicines Corporation | Sell | -5,556-22.4% |
Q4 2023Dec 31, 2023 | IDXX IDEXX Laboratories, Inc. | Sell | -9,008-95.9% |
Q4 2023Dec 31, 2023 | CPRT Copart, Inc. | Sell | -11,227-7.3% |
Q4 2023Dec 31, 2023 | VICR Vicor Corporation | Sell - Position Exit | -20,764-100.0% |
Q4 2023Dec 31, 2023 | TROW T. Rowe Price Group, Inc. | Sell | -30,946-24.3% |
Q4 2023Dec 31, 2023 | CCI Crown Castle Inc. | Sell - Position Exit | -37,144-100.0% |
Q4 2023Dec 31, 2023 | MO Altria Group, Inc. | Sell | -41,282-13.1% |
Q4 2023Dec 31, 2023 | KHC The Kraft Heinz Company | Sell | -43,636-16.2% |
Q4 2023Dec 31, 2023 | GM General Motors Company | Sell - Position Exit | -262,180-100.0% |
Q3 2023Sep 30, 2023 | CPRT Copart, Inc. | Buy | +73,228+91.9% |
Q3 2023Sep 30, 2023 | CCI Crown Castle Inc. | Buy | +11,532+45.0% |
Q3 2023Sep 30, 2023 | ENB Enbridge Inc | Buy | +6,464+9.5% |
Q3 2023Sep 30, 2023 | RCKT Rocket Pharmaceuticals, Inc. | Buy | +5,608+10.3% |
Q3 2023Sep 30, 2023 | MO Altria Group, Inc. | Buy | +4,318+1.4% |
Q3 2023Sep 30, 2023 | VICR Vicor Corporation | Buy | +4,246+25.7% |
Q3 2023Sep 30, 2023 | BMRN BioMarin Pharmaceutical Inc. | Buy | +3,241+29.5% |
Q3 2023Sep 30, 2023 | GILD Gilead Sciences, Inc. | Buy | +2,968+9.1% |
Q3 2023Sep 30, 2023 | CSCO Cisco Systems, Inc. | Buy | +2,675+5.7% |
Q3 2023Sep 30, 2023 | ABBV AbbVie Inc. | Buy | +2,446+13.0% |
Q3 2023Sep 30, 2023 | MRK Merck & Company, Inc. | Buy - Position Entry | +2,041 |
Q3 2023Sep 30, 2023 | QCOM QUALCOMM Incorporated | Buy | +2,036+1.9% |
Q3 2023Sep 30, 2023 | PAYX Paychex, Inc. | Buy | +2,010+10.9% |
Q3 2023Sep 30, 2023 | SPNS Sapiens | Buy | +1,556+3.7% |
Q3 2023Sep 30, 2023 | AVGO Broadcom Inc. | Buy | +1,512+21.1% |
Q3 2023Sep 30, 2023 | AMZN Amazon.com, Inc. | Buy | +1,442+1.8% |
Q3 2023Sep 30, 2023 | LYB LyondellBasell | Buy | +1,323+4.2% |
Q3 2023Sep 30, 2023 | TROW T. Rowe Price Group, Inc. | Buy | +1,256+1.0% |
Q3 2023Sep 30, 2023 | RYAN Ryan Specialty Holdings, Inc. | Buy | +1,064+2.7% |
Q3 2023Sep 30, 2023 | BPMC Blueprint Medicines Corporation | Buy | +1,051+4.4% |